News + Filings Transactions
|
Malik Rajesh
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
07/05/2023 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 1.4k | $2.45 | $3.3k | | 07/05/2023 |
06/01/2023 | POINT Biopharma Global Inc. | PNT | Grant | Stock Option (Right to Buy) | 44.7k | $9.12 | $408.1k | | 06/01/2023 |
05/10/2023 | G1 Therapeutics, Inc. | GTHX | Grant | Common Stock | 35k | $0.00 | $0 | | 05/10/2023 |
01/05/2023 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 729 | $5.41 | $3.9k | | 01/03/2023 |
01/04/2023 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 1.6k | $5.58 | $9.1k | | 01/03/2023 |
01/03/2023 | G1 Therapeutics, Inc. | GTHX | Grant | Common Stock | 17.9k | $0.00 | $0 | | 01/03/2023 |
01/03/2023 | G1 Therapeutics, Inc. | GTHX | Grant | Stock Options (Right to buy) | 35.7k | $5.73 | $204.6k | | 01/03/2023 |
12/15/2022 | G1 Therapeutics, Inc. | GTHX | Exercise | Stock Option (Right to Buy) | 14k | $0.30 | $4.2k | | 12/15/2022 |
11/28/2022 | POINT Biopharma Global Inc. | PNT | Purchase | Common Stock | 3.7k | $6.66 | $24.6k | | 11/28/2022 |
09/13/2022 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 18k | $15.71 | $282.7k | | 09/13/2022 |
09/13/2022 | G1 Therapeutics, Inc. | GTHX | Exercise | Stock Options (Right to Buy) | 18k | $0.39 | $7k | | 09/13/2022 |
07/05/2022 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 648 | $5.17 | $3.4k | | 07/05/2022 |
06/02/2022 | POINT Biopharma Global Inc. | PNT | Grant | Stock Option (Right to Buy) | 25.6k | $8.31 | $212.9k | | 06/02/2022 |
02/01/2022 | G1 Therapeutics, Inc. | GTHX | Exercise | Stock Option (Right to Buy) | 10k | $0.30 | $3k | | 02/01/2022 |
01/05/2022 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 1.4k | $10.61 | $15.3k | | 01/03/2022 |
01/03/2022 | G1 Therapeutics, Inc. | GTHX | Grant | Common Stock | 12k | $0.00 | $0 | | 01/03/2022 |
01/03/2022 | G1 Therapeutics, Inc. | GTHX | Grant | Stock Options (Right to buy) | 53k | $10.69 | $566.6k | | 01/03/2022 |
07/06/2021 | POINT Biopharma Global Inc. | PNT | Grant | Stock Option (Right to Buy) | 25k | $8.47 | $211.8k | | 07/06/2021 |
05/10/2021 | G1 Therapeutics, Inc. | GTHX | Exercise | Stock Option (Right to Buy) | 10k | $0.30 | $3k | | 05/10/2021 |
04/22/2021 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 15k | $22.07 | $331.1k | | 04/22/2021 |
04/22/2021 | G1 Therapeutics, Inc. | GTHX | Exercise | Stock Options (Right to Buy) | 15k | $0.39 | $5.8k | | 04/22/2021 |
03/23/2021 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 15k | $21.94 | $329.1k | | 03/23/2021 |
03/23/2021 | G1 Therapeutics, Inc. | GTHX | Exercise | Stock Options (Right to Buy) | 15k | $0.39 | $5.8k | | 03/23/2021 |
03/02/2021 | G1 Therapeutics, Inc. | GTHX | Exercise | Stock Option (Right to Buy) | 4.6k | $4.17 | $19.2k | | 03/02/2021 |
03/02/2021 | G1 Therapeutics, Inc. | GTHX | Exercise | Stock Options (Right to Buy) | 10.4k | $0.39 | $4.1k | | 03/02/2021 |
03/02/2021 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 15k | $22.95 | $344.2k | | 03/02/2021 |
01/27/2021 | G1 Therapeutics, Inc. | GTHX | Exercise | Stock Options (Right to Buy) | 3.1k | $0.39 | $1.2k | | 01/27/2021 |
01/22/2021 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 15k | $20.64 | $309.6k | | 01/22/2021 |
01/22/2021 | G1 Therapeutics, Inc. | GTHX | Exercise | Stock Option (Right to Buy) | 15k | $4.17 | $62.6k | | 01/22/2021 |
01/04/2021 | G1 Therapeutics, Inc. | GTHX | Grant | Common Stock | 11k | $0.00 | $0 | | 01/04/2021 |
01/04/2021 | G1 Therapeutics, Inc. | GTHX | Grant | Stock Options (Right to Buy) | 58k | $18.07 | $1M | | 01/04/2021 |
12/10/2020 | G1 Therapeutics, Inc. | GTHX | Exercise | Stock Option (Right to Buy) | 9k | $4.17 | $37.5k | | 12/10/2020 |
12/10/2020 | G1 Therapeutics, Inc. | GTHX | Sale | Common Stock | 9k | $20.06 | $180.5k | | 12/10/2020 |
03/13/2020 | G1 Therapeutics, Inc. | GTHX | Exercise | Stock Options (Right to Buy) | 2.5k | $0.39 | $975 | | 03/13/2020 |
02/06/2020 | G1 Therapeutics, Inc. | GTHX | Grant | Stock Options (Right to Buy) | 60k | $21.08 | $1.3M | | 02/06/2020 |
|
|